← Back to Search resultsInvestor profile:
Investor profile:
OrbiMed

Address:New York, New York, United States
Country:
Industries:
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Deals total: 223
As lead investor: 111
Also as a second investor: 10
As a second investor: 102
September 24, 2025$95mSecond investor
September 24, 2025
$95m
Sparrow Pharmaceuticals Raises $95M in Series B Financing
Second investor
Sparrow Pharmaceuticals Raises $95M in Series B Financing
September 22, 2025$60mLead investor
September 22, 2025
$60m
Avenzo Therapeutics Raised $60M in Series B Funding
Lead investor
Avenzo Therapeutics Raised $60M in Series B Funding
September 8, 2025$60mSecond investor
September 8, 2025
$60m
Epigenic Therapeutics Closes $60M Series B Financing
Second investor
Epigenic Therapeutics Closes $60M Series B Financing
September 4, 2025$32mLead investor
September 4, 2025
$32m
Congruence Therapeutics Raises $32M in Funding
Lead investor
Congruence Therapeutics Raises $32M in Funding
September 2, 2025
September 2, 2025